Skip to main content
Clinical Trials/KCT0000623
KCT0000623
Recruiting
未知

A prospective, single-center, randomized study to evaluate the effect of sarpogrelate, a selective serotonin receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients with variant angina

Samsung Medical Center0 sites200 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Samsung Medical Center
Enrollment
200
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Age 20 \~ 70 years old
  • 2\) Clinical history of chest pain compatible with variant angina; morning
  • chest pain aggravated by cold exposure.
  • 3\) Angiographically proven coronary spasm; TIMI flow \< 3 by spontaneous
  • coronary spasm or intracoronary ergonovine spasm provocation test.

Exclusion Criteria

  • 1\) Cardiac arrest by coronary spasm
  • 2\) Left main coronary spasm
  • 3\) Significant fixed coronary artery stenosis; Diameter stenosis \> 70% in the
  • major epicardial artery by coronary angiography
  • 4\) LV ejection fraction \< 30%
  • 5\) Coagulation disorders or bleeding tendency
  • (Platelet count \< 50k, PT INR \> 2\.0\)
  • 6\) Significant liver disease (AST or ALT \> 100 U/ml)
  • 7\) Renal failure (S\-Cr \> 2\.0 mg/dl)
  • 8\) hypersensitivity for statin

Outcomes

Primary Outcomes

Not specified

Similar Trials